RCKT
Rocket Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $415.43M | Price | $3.77 |
| Volume | 1.86M | Change | +1.89% |
| P/E Ratio | -1.6 | Open | $3.70 |
| Revenue | -- | Prev Close | $3.70 |
| Net Income | $-258.7M | 52W Range | $2.19 - $18.17 |
| Div Yield | N/A | Target | $7.56 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 41 |
No chart data available
Stock Overview
Updated DailyRocket Pharmaceuticals Inc. (RCKT) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.77 with a market capitalization of $415.43 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RCKT with a volume of 1.86 million shares. The stock opened down 0.00% from yesterday's close of $3.70. Current analyst estimates project earnings of $-2.06 per share for this year, with next year targeting $-1.35.
RCKT demonstrates weak technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RCKT include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 100.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCKT | $3.77 | +1.9% | 1.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rocket Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW